About QVQuality
QVQuality is a company based in Utrecht (Netherlands) founded in 2010. QVQuality offers products and services including Single-domain Antibodies, Phage Display Libraries, and Recombinant sdAbs. QVQuality operates in a competitive market with competitors including Evotec, Crown Bioscience, Alloy Therapeutics, CatSci and NIH, among others.
- Headquarter Utrecht, Netherlands
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Jurisdiction Gurgaon, Haryana, India
-
Annual Revenue
$5.32 K (USD)0as on Mar 31, 2016
-
Net Profit
-$79.52 K (USD)0as on Mar 31, 2016
-
EBITDA
-$79.57 K (USD)0as on Mar 31, 2016
-
Latest Funding Round
$309.44 K (USD), Grant
Feb 01, 2020
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of QVQuality
QVQuality offers a comprehensive portfolio of products and services, including Single-domain Antibodies, Phage Display Libraries, and Recombinant sdAbs.
Well-characterized antibodies for research with conjugation options.
Custom libraries for antibody selection and discovery processes.
Produced antibodies with tags for various research applications.
Funding Insights of QVQuality
Investors in QVQuality
QVQuality has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for QVQuality
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by QVQuality
Investment portfolio details for QVQuality
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - QVQuality
Detailed financials for QVQuality
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Qvquality Comparisons
Peer comparison for QVQuality
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of QVQuality
QVQuality operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evotec, Crown Bioscience, Alloy Therapeutics, CatSci and NIH, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery and development services are provided to biopharma sector.
|
|
| Locked | Locked | Locked |
Cancer and CVMD drugs are developed using PDX models.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided for therapeutic development.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided to pharmaceutical clients worldwide.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided to the biopharma sector.
|
|
| Locked | Locked | Locked |
Drug discovery CRO company for epigenetic research and inflammatory diseases
|
Detailed competitors of QVQuality
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Qvquality
Complete news archive for QVQuality
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about QVQuality
QVQuality was founded in 2010 and raised its 1st funding round 5 years after it was founded.
QVQuality is headquartered in Utrecht, Netherlands.
Annual revenue of QVQuality is $5.32K as on Mar 31, 2016.
QVQuality was founded in 2010 in Utrecht, Netherlands, as a biotech firm focused on the discovery and development of single-domain antibody fragments and VHH antibodies. Services provided include lead panel antibody discovery, phage display, functionalization, llama immunization, and biopanning. These offerings support the creation of therapeutics and diagnostics in the research and development sector. Operations are centered in the Netherlands, emphasizing high-quality antibody products.
QVQuality's top competitors include Evotec, Crown Bioscience and NIH.
QVQuality offers Single-domain Antibodies, Phage Display Libraries, and Recombinant sdAbs.
QVQuality has 1 investor. Key investors include European Union.